SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Dr Reddys Lab reports 7% rise in Q1FY14 consolidated net profit

30 Jul 2013 Evaluate

Dr Reddys Laboratories has reported results for the quarter ended June 30, 2013.

The company’s net profit declined by 63.49% at Rs 64.86 crore for the quarter as compared to Rs 177.66 crore for the same quarter in the previous year. Total income of the company has increased by 1.09% at Rs 1854.93 crore for quarter under review as compared to Rs 1834.94 crore for the quarter ended June 30, 2012.

On consolidated basis, the Group’s net profit after taxes rose by 7.45% at Rs 360.93 crore for the quarter under review as compared to Rs 335.98 crore for the June quarter of the previous year. Its total income has increased by 12.49% to Rs 2882.48 crore in Q1FY14 against Rs 2562.46 crore in Q1FY13.

Dr. Reddys Labs. Share Price

1356.85 -19.45 (-1.41%)
30-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1862.70
Dr. Reddys Labs. 1356.85
Cipla 1465.15
Zydus Lifesciences 1112.20
Lupin 2420.15
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: